Clinical Trials Directory

Trials / Completed

CompletedNCT02820259

Therapeutic Drug Monitoring of Tacrolimus Biliary Concentrations for Liver-transplanted Patients (STABILE)

Status
Completed
Phase
—
Study type
Observational
Enrollment
42 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to demonstrate that the biliary concentration of TCR is a good marker of its immunosuppressive activity.

Conditions

Interventions

TypeNameDescription
DRUGTacrolimus

Timeline

Start date
2016-05-01
Primary completion
2017-04-07
Completion
2017-04-07
First posted
2016-06-30
Last updated
2017-09-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02820259. Inclusion in this directory is not an endorsement.

Therapeutic Drug Monitoring of Tacrolimus Biliary Concentrations for Liver-transplanted Patients (STABILE) (NCT02820259) · Clinical Trials Directory